Evidence map›Paper›PMID 38226066›Full record

ArticleERJ open research2024

Stefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, Andrea Calcagno, Andreas Fløe, Dorothy Grogono, Apostolos Papavasileiou, Eva Polverino, Concepción Prados, Gernot Rohde and 8 more

Abstract read
In one paragraph

Article in ERJ open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Macrolide-resistantJournal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
  2. Observational
  3. Article
  4. Growing from common ground: nontuberculous mycobacteria and bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Stefano AlibertiDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.ORCID https://orcid.org/0000-0002-0090-4531
Francesco BlasiDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.ORCID https://orcid.org/0000-0002-2285-9970
Pierre-Régis BurgelRespiratory Medicine, Université Paris Cité, Inserm U1016, Institut Cochin, Paris, France.ORCID https://orcid.org/0000-0003-0903-9828
Andrea CalcagnoDepartment of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.
Andreas FløeDepartment of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark.
Dorothy GrogonoCambridge Centre of Lung Infection, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Apostolos Papavasileiou"Sotiria" General Hospital of Chest Diseases, Athens, Greece.
Eva PolverinoRespiratory Medicine, Adult Bronchiectasis and Cystic Fibrosis, University Hospital Vall D'Hebron, VHIR, CIBERES, Barcelona, Spain.
Concepción PradosPulmonology, Cystic fibrosis, Bronchiectasis, Bronquial Infections, La Paz University Hospital, Madrid, Spain.
Gernot RohdeGoethe University Frankfurt, University Hospital, Medical Clinic 1, Respiratory Medicine and Allergology, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-5193-7755
Helmut J F SalzerDivision of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria.
Adrián Sánchez-MontalváInternational Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS, Universitat Autónoma de Barcelona, Barcelona, Spain.
Michal ShteinbergCarmel Medical Center and the Technion-Israel Institute of Technology, B. Rappaport Faculty of Medicine, Haifa, Israel.ORCID https://orcid.org/0000-0002-0432-3398
Eva Van BraeckelDepartment of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0002-7242-0747
Jakko van IngenClinical Microbiologist, Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0002-0581-2003
Nicolas VezirisSorbonne Université, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), UMR 1135, Department of Bacteriology, Saint-Antoine Hospital, APHP, Sorbonne-Université, Centre National de Référence des Mycobactéries, Paris, France.ORCID https://orcid.org/0000-0001-5660-6544
Dirk WagnerDepartment of Internal Medicine II, Division of Infectious Diseases, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0002-3271-5815
Michael R LoebingerHost Defence Unit, Royal Brompton Hospital, and NHLI, Imperial College, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38226066
PMCPMC10789256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.